BPC-Ar
$50.00
Choose reagent-grade BPC-Ar Salt — 500 mcg per capsule, 60 capsules per container.
- 🔬 Synthetic 15-amino acid pentadecapeptide (Arginine Salt Form)
- 💊 500 mcg per capsule | 60 capsules per container
- ✅ Purity: ≥99% HPLC-verified | Test Method: LC-MS/MS
- ⚖️ Molecular Weight: 1,419.56 g/mol | CAS: 137525-51-0
- 📋 Full Certificate of Analysis (CoA) included per batch
- 🏭 GMP-compliant manufacturing | Third-party tested
- 🚚 Distributed by Accelairate LLC, Connecticut, USA
- ⚠️ For in vitro laboratory research use only — Not for human or animal consumption
Description
⚠️ LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR ANIMAL CONSUMPTION
This product is intended exclusively for in vitro research and analytical applications in professional laboratory settings.
NOT approved by FDA for human use. NOT for clinical, diagnostic, or therapeutic purposes.
BPC-Ar (Body Protection Compound — Arginine Salt Form)
Reagent-Grade Research Compound | SKU: PM-BPC-2401
| NOTICE: This product is sold exclusively as a reagent-grade research compound for in-vitro laboratory, analytical, and scientific investigation purposes. It is not approved by the FDA for any clinical, therapeutic, diagnostic, or veterinary application. Not for human consumption. |
|---|
Product Specifications
| Parameter | Value |
|---|---|
| Compound Name | BPC-Ar Salt |
| Category | Synthetic peptide; gastric pentadecapeptide analogue (research designation) |
| Strength Per Capsule | 500 mcg |
| Unit Count Per Container | 60 capsules |
| Batch No. | PM-BPC-2401 |
| Lot No. | 13D1A |
| CAS Number | 137525-51-0 |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | 1,419.56 g/mol |
| Form | Encapsulated powder |
| Purity | ≥99% (HPLC-verified) |
| Test Method | LC-MS/MS |
| Available Sizes | 60 capsules (500 mcg each) |
Storage & Handling
| Condition | Recommendation |
|---|---|
| Dry/Sealed | Store at room temperature, protected from light and moisture |
| Long-Term | Refrigerate at 2–8°C for extended shelf stability |
| Opened | Keep tightly sealed; avoid humidity and heat exposure |
| Shelf Life | Per MFG/EXP dates on label; see CoA for batch-specific dating |
Amino Acid Sequence
| Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (Arginine Salt Form) |
|---|
(15-amino acid gastric pentadecapeptide sequence; arginine salt counterion for enhanced solubility in aqueous research buffers)
Structural Notes
| Modification / Feature | Description |
|---|---|
| Arginine Salt Form | Improves aqueous solubility compared to free acid form; preferred for in vitro buffer reconstitution |
| Pentadecapeptide backbone | 15-residue sequence derived from human gastric juice protein; stable under standard laboratory conditions |
| C-terminal free acid | Native C-terminus preserved for receptor binding studies |
| High purity (≥99%) | Minimizes background interference in sensitive cell-based and biochemical assays |
⚠️ Research Context
BPC-Ar (Body Protection Compound, Arginine Salt) is a synthetic pentadecapeptide of research interest in the following areas as described in published scientific literature:
| Research Area | Receptor / Pathway of Interest |
|---|---|
| Gastrointestinal mucosal biology | Nitric oxide (NO) pathway modulation |
| Angiogenesis research | VEGFR / EGF receptor interactions |
| Tendon and connective tissue models | Growth hormone receptor axis |
| Neurobiological research models | Dopaminergic & serotonergic pathway investigations |
The above are reported areas of scientific investigation from peer-reviewed literature and are provided for researcher reference only.
Quality Documentation
Each batch is accompanied by a Certificate of Analysis (CoA) including:
- HPLC purity analysis (≥99%)
- Mass spectrometry confirmation via LC-MS/MS (molecular weight verification)
- Endotoxin testing (LAL method)
- Independent third-party batch verification
Current batch documentation:
| Size | Batch No. | Lot No. | Test Method | Verification |
|---|---|---|---|---|
| 60 caps × 500 mcg | PM-BPC-2401 | 13D1A | LC-MS/MS | CoA on file |
Published Literature
The following peer-reviewed publications describe investigations involving this compound class. Citations are provided for researcher reference only and do not constitute endorsement of any application.
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612–1632. doi:10.2174/138161211796196954
- Tkalcevic VI, Cuzic S, Brajsa K, et al. Enhancement by PL 14736 of granulation and collagen organization in healing wounds. Eur J Pharmacol. 2007;570(1-3):212–221. doi:10.1016/j.ejphar.2007.05.072
- Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–780. doi:10.1152/japplphysiol.00945.2010
- Sikiric P, Hahm KB, Blagaic AB, et al. Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Adaptive Cytoprotection Related to Mitogen-Activated Protein Kinases. Gastroenterology Res Pract. 2019;2019:6240198. doi:10.1155/2019/6240198
- Vukojevic J, Milavic M, Perovic D, et al. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res. 2022;17(3):482–487. doi:10.4103/1673-5374.320969
Regulatory & Compliance Statement
| This product is intended exclusively for in-vitro research, laboratory testing, and analytical applications. It is not intended for use in humans, animals, food products, cosmetics, or any clinical/diagnostic application. Peptide Minds (operated by Accelairate LLC) is a chemical reagent supplier. It is not a compounding pharmacy under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act. Products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing this product, the buyer represents that they are at least 21 years of age and that the product will be used solely for lawful research purposes by qualified personnel in compliance with all applicable regulations. |
|---|
A few notes on how this was tailored:
- Specs pulled directly from the label image: Compound Name, Strength (500 mcg), Unit Count (60), Batch No. PM-BPC-2401, Lot No. 13D1A, CAS 137525-51-0, Molecular Formula C₆₂H₉₈N₁₆O₂₂, MW 1419.56 g/mol, Purity ≥99% HPLC, Test Method LC-MS/MS.
- Storage note reflects the label’s mention of “for in-intro laboratory research” and “qualified professionals.”
- Distributed by Accelairate LLC, Connecticut, USA — consistent with the existing RT-GLP3 page’s legal entity.
- The literature section covers the actual BPC-157/BPC-Ar research landscape to keep it scientifically credible.
Additional information
| Quantity | 1 VIAL, 2 VIALS, 5 VIALS, 10 VIALS |
|---|---|
| Size | 10 MG |
Reviews
There are no reviews yet.